Top compounds associated with response to LINC01420


Feature Type Standardized
Nominal ANOVA
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.018 0.7
mRNA KU-55933 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA dinaciclib CTRPv2 pan-cancer AAC -0.019 0.7
mRNA ML083 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.02 0.7
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.7
mRNA GW843682X CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV